William C Goedel1, Maximilian R F King1, Mark N Lurie1, Amy S Nunn2,3, Philip A Chan2,4, Brandon D L Marshall1. 1. Department of Epidemiology, School of Public Health, Brown University, Providence, RI. 2. Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI. 3. Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI. 4. Division of Infectious Diseases, The Miriam Hospital, Providence, RI.
Abstract
BACKGROUND: Pre-exposure prophylaxis (PrEP) uptake has been slow among African American men who have sex with men (AAMSM) in the United States. We used an agent-based model (ABM) to simulate race-specific PrEP coverage to estimate their impact on racial disparities in HIV incidence among MSM in Atlanta, GA. METHODS: An ABM was constructed to simulate HIV transmission in a dynamic network of 10,000 MSM over 10 years, beginning in 2015. We modeled a base scenario with estimated PrEP coverage of 2.5% among AAMSM and 5.0% among white MSM (WMSM). We then compared HIV incidence over 10 years and calculated a disparity ratio of AAMSM to WMSM incidence rates across varying PrEP scale-up scenarios, with equal and unequal coverage among AAMSM and WMSM. RESULTS: Assuming current coverage remains constant, the model predicts HIV incidence rates of 2.95 and 1.76 per 100 person-years among AAMSM and WMSM, respectively, with a disparity ratio of 1.68. If PrEP coverage was to increase 6-fold without addressing inequities in PrEP uptake, the model predicts incidences of 2.65 and 1.34, corresponding to a mean decrease of 10.4% and 24.0% in HIV incidence, respectively. This stronger benefit for WMSM increased the disparity ratio to 1.98. Equal PrEP coverage among AAMSM and WMSM resulted in lower incidence rates overall with lower disparity ratios. CONCLUSIONS: Lower uptake among AAMSM relative to WMSM may limit the population-level impact of PrEP use among AAMSM, which may ultimately culminate in wider racial disparities in HIV incidence among MSM.
BACKGROUND: Pre-exposure prophylaxis (PrEP) uptake has been slow among African American men who have sex with men (AAMSM) in the United States. We used an agent-based model (ABM) to simulate race-specific PrEP coverage to estimate their impact on racial disparities in HIV incidence among MSM in Atlanta, GA. METHODS: An ABM was constructed to simulate HIV transmission in a dynamic network of 10,000 MSM over 10 years, beginning in 2015. We modeled a base scenario with estimated PrEP coverage of 2.5% among AAMSM and 5.0% among white MSM (WMSM). We then compared HIV incidence over 10 years and calculated a disparity ratio of AAMSM to WMSM incidence rates across varying PrEP scale-up scenarios, with equal and unequal coverage among AAMSM and WMSM. RESULTS: Assuming current coverage remains constant, the model predicts HIV incidence rates of 2.95 and 1.76 per 100 person-years among AAMSM and WMSM, respectively, with a disparity ratio of 1.68. If PrEP coverage was to increase 6-fold without addressing inequities in PrEP uptake, the model predicts incidences of 2.65 and 1.34, corresponding to a mean decrease of 10.4% and 24.0% in HIV incidence, respectively. This stronger benefit for WMSM increased the disparity ratio to 1.98. Equal PrEP coverage among AAMSM and WMSM resulted in lower incidence rates overall with lower disparity ratios. CONCLUSIONS: Lower uptake among AAMSM relative to WMSM may limit the population-level impact of PrEP use among AAMSM, which may ultimately culminate in wider racial disparities in HIV incidence among MSM.
Authors: David R Hunter; Mark S Handcock; Carter T Butts; Steven M Goodreau; Martina Morris Journal: J Stat Softw Date: 2008-05-01 Impact factor: 6.440
Authors: Charlotte-Paige Rolle; Eli S Rosenberg; Aaron J Siegler; Travis H Sanchez; Nicole Luisi; Kevin Weiss; Scott Cutro; Carlos Del Rio; Patrick S Sullivan; Colleen F Kelley Journal: J Acquir Immune Defic Syndr Date: 2017-11-01 Impact factor: 3.731
Authors: H Jonathon Rendina; Thomas H F Whitfield; Christian Grov; Tyrel J Starks; Jeffrey T Parsons Journal: Soc Sci Med Date: 2016-11-18 Impact factor: 4.634
Authors: Gregorio A Millett; John L Peterson; Stephen A Flores; Trevor A Hart; William L Jeffries; Patrick A Wilson; Sean B Rourke; Charles M Heilig; Jonathan Elford; Kevin A Fenton; Robert S Remis Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Samuel M Jenness; Steven M Goodreau; Eli Rosenberg; Emily N Beylerian; Karen W Hoover; Dawn K Smith; Patrick Sullivan Journal: J Infect Dis Date: 2016-07-14 Impact factor: 5.226
Authors: Nathan W Stupiansky; Adrian Liau; Joshua Rosenberger; Susan L Rosenthal; Wanzhu Tu; Shan Xiao; Holly Fontenot; Gregory D Zimet Journal: AIDS Patient Care STDS Date: 2017-08 Impact factor: 5.078
Authors: Rupa R Patel; Leandro Mena; Amy Nunn; Timothy McBride; Laura C Harrison; Catherine E Oldenburg; Jingxia Liu; Kenneth H Mayer; Philip A Chan Journal: PLoS One Date: 2017-05-30 Impact factor: 3.240
Authors: Ashley L Buchanan; S Bessey; William C Goedel; Maximilian King; Eleanor J Murray; Samuel R Friedman; M Elizabeth Halloran; Brandon D L Marshall Journal: Am J Epidemiol Date: 2021-05-04 Impact factor: 4.897
Authors: William C Goedel; Amy S Nunn; Philip A Chan; Dustin T Duncan; Katie B Biello; Steven A Safren; Brandon D L Marshall Journal: AIDS Date: 2019-11-01 Impact factor: 4.177
Authors: Alyson L Singleton; Brandon D L Marshall; Xiao Zang; Amy S Nunn; William C Goedel Journal: AIDS Patient Care STDS Date: 2020-11-19 Impact factor: 5.078
Authors: Aditya S Khanna; John A Schneider; Nicholson Collier; Jonathan Ozik; Rodal Issema; Angela di Paola; Abigail Skwara; Arthi Ramachandran; Jeannette Webb; Russell Brewer; William Cunningham; Charles Hilliard; Santhoshini Ramani; Kayo Fujimoto; Nina Harawa Journal: AIDS Date: 2019-10-01 Impact factor: 4.177
Authors: Krishna Kiran Kota; Gordon Mansergh; Rob Stephenson; Sabina Hirshfield; Patrick Sullivan Journal: AIDS Patient Care STDS Date: 2021-04-23 Impact factor: 5.078